[Chemiluminescence of blood plasma and functional status of the erythrocytes of patients with various hereditary neuromuscular diseases].
The authors studied the parameters of osmotic resistance and deformability of erythrocytes in patients with Duchenne's, Bekker's, Erb-Roth's and Landouzy-Déjérine's progressive muscular dystrophies, with Charcot-Marie's spinal amyotrophy, Kugelberg-Welander neural amyotrophy and with Thomsen's myotonia. Along with an increase in the erythrocytic osmotic resistance and deformability patients with different forms of hereditary neuromuscular diseases showed decreased plasma chemiluminescence (PCL) as well as an elevated ability of the blood plasma to inhibit PCL in the model chemiluminescence system in patients with Duchenne's progressive muscular dystrophy and in their close relatives.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003402:Creatine Kinase / Q000097:blood; D004907:Erythrocyte Deformability; D004912:Erythrocytes / Q000502:physiology*; D005260:Female; D006801:Humans; D008163:Luminescent Measurements; D008297:Male; D009133:Muscular Atrophy / Q000097:blood; D009136:Muscular Dystrophies / Q000097:blood; D009224:Myotonia Congenita / Q000097:blood; D009468:Neuromuscular Diseases / Q000097:blood* / Q000235:genetics; D009996:Osmotic Fragility; D013577:Syndrome
D003402:Creatine Kinase
Khemiliuminestsentsiia plazmy krovi i funktsional'noe sostoianie éritrotsitov u bol'nykh s nekotorymi nasledstvennymi nervno-myshechnymi zabolevaniiami.